Autoimmune diseases associated to Transverse Myelitis. Review;Mielitis Transversa asociada a enfermedades autoinmunes. Revisión

Investigacion Clinica

Volumn 50, Issue 2, 2009, Pages 251-270

  Tristano, Antonio G ^a,b  

^a Centro Medico Docente La Trinidad   (Venezuela)

^b Edif Tamanaco   (Venezuela)

Author keywords

Acute transverse myelitis; Antiphospholipid antibodies; Sj gren's syndrome; Systemic lupus erythematosus; Transverse myelopathy

Indexed keywords

PHOSPHOLIPID ANTIBODY; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; HUMAN; MYELITIS; PROGNOSIS; REVIEW; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; CHILD; FEMALE; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; MULTIMODALITY CANCER THERAPY; NEUROLOGIC DISEASE; PLASMAPHERESIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CHILD; COMBINED MODALITY THERAPY; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; MYELITIS, TRANSVERSE; PLASMAPHERESIS; SJOGREN'S SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349571914     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Review

References (140)

1. The Transverse Myelitis Consortium Working Group. Neurology 2002; 59:499-505.
2. Kerr DA, Ayetey H. Immunopathogenesis of acute transverse myelitis. Curr Opin Neurol 2002; 15:339-347.
3. Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse Myelitis: pathogenesis, diagnosis and treatment. Front Biosci 2004; 9:1483-1499.
4. Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ. Transverse myelopathy in systemic lupus erythematosus: an analisis of 14 cases and review of the literature. Ann Rheum Dis 2000; 59:120-124. (Pubitemid 30305609)
5. Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: Incidence and etiologic considerations. Neurology 1981; 31:966-971. (Pubitemid 11061734)
6. Alarcón-Segovia D, Deleze M, Oria CV. Antiphospholipid antibodies and the phospholipid syndrome in systemic lupus erythematosus. A prospective analisis of 500 patients. Medicine 1989; 30:947-950.
7. Aillievi A, Tangari N, Ferro H, Camera A. Transverse myelitis and systemic lupus erythematosus. A case report. Medicina (B Aires) 1991; 51(4):351-354.
8. Williams CS, Butler E, Roman GC. Treatment of myelopathy in Sjogren syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol 2001; 58: 815-819. (Pubitemid 32423055)
9. Hummers LK, Krishnan C, Casciola-Rosen L, Rosen A, Morris S, Mahoney JA, Kerr DA, Wigley FM. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 2004; 62:147-149. (Pubitemid 38082893)
10. Lavalle C, Pizarro S, Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 1990; 17:34-37. (Pubitemid 20070564)
11. Mok CC, Lau CS, Chan YET, Wong RWS. Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. J Rheumatol 1998; 25:467-473
12. Tristano AG. Acute transverse myelitis as part of the catastrophic antiphospholipid syndrome in a systemic lupus erythematosus patient. Neurologia 2004; 19(10): 774-775.
13. D'Cruz DP, Mellor-Pita S, Joven B, Sanna G, Allanson J, Taylor J, Khamashta MA, Hughes GR. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of anti-phospholipid antibodies. J Rheumatol 2004; 31(2):280-285.
14. Huang TY, Sileo DR, Huang JT, Postel GC, Abaskaron M, Aaron JO. MR imaging of acute transverse myelitis. J Ky Med Assoc 1999; 97(4):165-167.
15. Zenone T, Steineur MP, Sibille M, Durieu I, Vital Durand D. Myelopathy revealing lupus. Two cases and review of the literature. Rev Med Interne 2000; 21(12):1114-1120.
16. Chan KF, Boey ML. Transverse myelopathy in SLE: clinical features and functional outcomes. Lupus 1996; 5:294-299.
17. Chang R, Quismorio FP Jr. Transverse myelopathy in systemic lupus erythematosus (SLE). Arthritis Rheum 1990; 33 Suppl 9:102.
18. Kasitanon N, Louthrenoo W, Piyasirisilp S, Sukitawu W, Wichainun R. Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 2002; 20(3):179-185. (Pubitemid 36253669)
19. Vincent TL, Richardson MP, Mackworth-Young CG, Hawke SH, Venables PJ. Sjögren's syndrome-associated myelopathy: Response to immunosuppressive treatment. Am J Med 2003; 114(2):145-148.
20. Rogers SJ, Williams CS, Román GC. Myelopathy in Sjogren's syndrome. Role of nonsteroidal immunosuppressants. Drugs 2004; 64:123-132.
21. Arabshahi B, Pollock AN, Sherry DD, Albert DA, Kreiger PA, Pessler F. Devic disease in a child with primary Sjogren syndrome. J Child Neurol. 2006; 21(4):285-286 (Pubitemid 43891123)
22. Tristano AG. A case of Sjogren's syndrome with acute transverse myelitis and polyneuropathy in a patient free of sicca symptoms. Clin Rheumatol 2006; 25(1):113-114.
23. Manabe Y, Sasaki H, Warita T, Hayashi T, Shiro Y, Sakai K, Kashihara K, Abe K. Sjögren's syndrome with acute transverse myelopathy as the initial manifestation. J Neurol Sci 2000; 176:158-161.
24. Yanagihara C, Nakaji K, Nishimura Y. A case of primary Sjogren's syndrome with acute transverse myelopathy and polyneuropathy as the initial manifestations. Rinsho Shinkeigaku. 2001; 41(1):50-55.
25. Arai C, Furutani R, Ushiyama M. A case of Sjogren's syndrome with subacute transverse myelitis as the initial manifestation. Rinsho Shinkeigaku 2002; 42(7):613-618.
26. Rutan G, Martinez A, Fieschko J, Van Thiel D. Primary biliary cirrhosis, Sjögren's syndrome, and transverse myelitis. Gastroenterology 1986; 90:206-210.
27. Linardaki G, Skopouli FN, Koufos C, Moutsopoulos HM. Subclinical multisystemic autoimmunity presenting as a progressive myelopathy. Lupus 1997; 6:675-677.
28. Wakatsuki T, Miyata M, Shishido S, Suzuki T, Ohira H, Kokubun M, Sato Y, Yamamoto T, Kasukawa R. Sjogren's syndrome with primary biliary cirrhosis, complicated by transverse myelitis and malignant lymphoma. Intern Med 2000; 39(3):260-265.
29. Anantharaju A, Baluch M, Van Thiel DH. Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome. Dig Dis Sci 2003; 48(4):830-833. (Pubitemid 36390693)
30. Konttinen Y, Kinnunen E, von Bonsdorff M, Lillqvist P, Immonen I, Bergroth V, Segerberg-Konttinen M, Friman C. Acute transverse myelopathy successfully treated with plasmapheresis and prednisone in a patient with primary Sjögren's syndrome. Arthritis Rheum 1987; 30:339-344. (Pubitemid 17098587)
31. Alexander E. Central nervous system disease in Sjogren's syndrome: new insights into immunopathogenesis. Rheum Dis Clin North Am 1992; 18(3):637-672.
32. Niemela RK, Hakala M. Primary Sjogren's syndrome with severe central nervous system disease. Semin Arthritis Rheum 1999; 29(1):4-13. (Pubitemid 29383438)
33. Klein R, Richter C, Berg PA. Antibodies against central nervous system tissue (anti-CNS) detected by ELISA and western blotting: marker antibodies for neuropsychiatric manifestations in connective tissue diseases. Autoimmunity 1991; 10:133-144.
34. Alexander EL, Ranzenbach MR, Kumar AJ, Kozachuk WE, Rosenbaum AE, Patronas N, Harley JB, Reichlin M. Anti-Ro(SS-A) autoantibodies in central nervous system disease associated with Sjogren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates. Neurology 1994; 44(5):899-908. (Pubitemid 24984748)
35. Rood MJ, Verschuuren JJ, van Duinen SG, Maat-Schieman ML, Hegeman-Kleinn IM, van Buchem MA, Breedveld FC, Huizinga TW. CNS involvement in primary Sjogren's syndrome: a case with a clue for the pathogenesis. J Neurol 2000; 247(1): 63-64.
36. Bakchine S, Duyckaerts C, Hassine L, Chaunu MP, Turell E, Wechsler B, Chain F. Central and peripheral neurologic lesions in primary Gougerot-Sjogren syndrome. Clinicopathological study of a case. Rev Neurol (Paris) 1991; 147(5):368-375.
37. Theodoridou A, Settas L. Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry 2006; 77(3):290-295.
38. Brey RL, Hart RG, Sherman DG, Tegeler CH. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40(8):1190-1196. (Pubitemid 20244973)
39. Levine SR, Deegan MJ, Futrell N, Welch KM. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology. 1990; 40(8): 1181-1189. (Pubitemid 20244972)
40. Levine SR, Brey RL. Neurological aspects of antiphospholipid antibody syndrome. Lupus 1996; 5:347-353. (Pubitemid 26354044)
41. Brey RL, Escalan A. Neurological manifestations of antiphospholipid antibody syndrome. Lupus 1998; 7(Suppl 2):S67-S74. (Pubitemid 28484585)
42. Shaharao V, Bartakke S, Muranjan MN, Bavdekar MS, Bavdekar SB, Udani1 VP. Recurrent acute transverse myelopathy: Association with antiphospholipid antibody síndrome Indian J Pediatr 2004; 71(6): 559-561.
43. Kim JH, Lee SI, Park SI, Yoo WH. Recurrent transverse myelitis in primary antiphospholipid syndrome -case report and literature review. Rheumatol Int 2004; 24(4):244-246. (Pubitemid 39062499)
44. Campi A, Filippi M, Comi G, Scotti G. Recurrent acute transverse myelopathy associated with anticardiolipin antibodies. Am J Neuroradiol 1998; 19:781-786. (Pubitemid 30422732)
45. Andrianakos AA, Duffy J, Suzuki M, Sharp JT. Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature. Ann Intern Med. 1975; 83(5):616-624.
46. Chapman J, Cohen-Armon M, Shoenfeld Y, Korczyn AD. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 1999; 8:127-133. (Pubitemid 29103599)
47. Harris EN, Baguley E, Asherson RA, Hughes GRV. Clinical and serological features of the antiphospholipid syndrome (APS). Br J Rheumatol 1987; 26:19.
48. Hughes GR, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986; 13:486-489.
49. Bick RL, Baker WF. Antiphospholipid and thrombosis syndromes. Semin Thromb Hemost 1994; 20:3-15.
50. Weatherby SJ, Davies MB, Hawkins CP, Haq N, Dawes P. Transverse myelopathy, a rare complication of mixed connective tissue disease: comparison with SLE related transverse myelopathy. J Neurol Neurosurg Psychiatry. 2000; 68(4):532-533. (Pubitemid 30248762)
51. Huang TY, Sileo DR, Huang JT, Postel GC, Abaskaron M, Aaron JO. MR imaging of acute transverse myelitis. J Ky Med Assoc 1999; 97:165-167.
52. Scotti G, Gerevini S. Diagnosis and differential diagnosis of acute transverse myelopathy. The role of neuroradiological investigations and review of the literature. Neurol Sci 2001; 22 (Suppl 2):S69-73.
53. Pros A, Ciria M, Maymo J, Blanch J. Lupus myelitis: value of magnetic resonance. Med Clin (Barc) 1998; 110(4):159.
54. Rodríguez Núñez FM, González Freire M, Graña Gil J, Atanes Sandoval A. Evolución y respuesta al tratamiento de un caso de mielitis. Rev Clin Esp 2002; 202(6): 358-363.
55. Wright R, O'Duffy J, Rodriguez M. Improvement of myelopathy in Sjögren's syndrome with chlorambucil and prednisone therapy. Neurology 1999; 52:386-388. (Pubitemid 29059070)
56. Weiner SM, Otte A, Schumacher M, Klein R, Gutfeisch J, Brink I, Otto P, Nitzche EU, Moser E, Peter HH. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 2000; 59:377-385. (Pubitemid 30316785)
57. Barile L, Lavalle C. Transverse myelitis in systemic lupus erythematosus -the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol 1992; 19:370-372.
58. de Macedo DD, de Mattos JP, Borges TM. Transverse myelopathy and systemic lupus erythematosus. Report of a case and review of the literature. Arq Neuropsiquiatr 1979; 37(1):76-84.
59. Kewalramani LS, Sallem S, Bertrand D. Myelopathy associated with systemic lupus erythematosus (erythema nodosum). Paraplejia 1979; 16:282-294.
60. Lyu R, Chem S, Tang L, Chen T. Acute transverse myelopathy and cutaneous vasculopathy in primary Sjögren's syndrome. Eur Neurol 1995; 35:359-362.
61. Quartuccio L, Ferraccioli GF, De Vita S. Transverse myelitis in primary Sjögren's syndrome: usefulness of oral low-dose cyclophosphamide rather than pulse therapy. Scand J Rheumatol 2006; 35(5):409-410.
62. Harisdangkul V, Doorenbos D, Subramony SH. Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol 1995; 242:326-331.
63. Yucesan C, Arslan O, Arat M, Yucemen N, Ayyildiz E, Ilhan O, Mutluer N. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: Review of 50 cases. Transfus Apher Sci 2007; 36(1): 103-107. (Pubitemid 46341969)
64. Trysberg E, Lindgren I, Tarkowski A. Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus. Ann Rheum Dis 2000; 59(3): 236-238. (Pubitemid 30305597)
65. Lee DM, Jeon HS, Yoo WH. Transverse myelitis in a patient with primary antiphospholipid syndrome. Yonsei Med J 2003; 44(2):323-327. (Pubitemid 36592196)
66. Ruiz-Arguelles GJ, Guzman-Ramos J, Flores-Flores J, Garay-Martinez J. Refractory hiccough heralding transverse myelitis in the primary antiphospholipid syndrome. Lupus. 1998; 7(1):49-50. (Pubitemid 28052662)
67. D'Amico A, Francia A, Paolella P, D'Amelio R. Transverse myelopathy caused by systemic lupus erythematosus (LES). Riv Neurol 1979; 49(5):367-373.
68. Orolin D, Travnik K. Acute transverse myelopathy in systemic lupus erythematosus. Cesk Neurol Neurochir 1980; 43(1):41-44.
69. Yokoyama Y, Kono T, Sano C. Transverse myelopathy in systemic lupus erythematosus -report of a case with long-term follow-up (author's transl). Nippon Naika Gakkai Zasshi 1981; 70(8):1153-1158.
70. Chong Yew Hock, Cheong I. Transverse myelopathy and hyperphagia in systemic lupus erythematosus: a case report. Med J Malaysia. 1985; 40(4):333-334. (Pubitemid 17221415)
71. Tamaoka A, Murayama S, Sonoh M, Matsumura K, Sakuta M. Two cases of retrobulbar neuritis and transverse myelopathy as the initial symptoms suggestive of systemic lupus erythematosus (SLE) -case report and review of literature. Rinsho Shinkeigaku 1986; 26(5):483-489.
72. Yamamoto M. Recurrent transverse myelitis associated with collagen disease. J Neurol 1986; 233(3):185-187. (Pubitemid 16114604)
73. Linssen WH, Fiselier TJ, Gabreels FJ, Wevers RA, Cuppen MP, Rotteveel JJ. Acute transverse myelopathy as the initial manifestation of probable systemic lupus erythematosus in a child. Neuropediatrics 1988; 19(4):212-215.
74. Shimamoto Y, Shimamoto H, Nakamura H. Transverse myelopathy and Gottron's sign associated with systemic lupus erythematosus in an elderly woman -a case report. Nippon Ronen Igakkai Zasshi. 1988; 25(3):309-315
75. Waga S, Nukii K, Sugimoto K, Tanaka H, Furukawa H, Sashinami T. Myelopathy, ascites and pleural effusion in systemic lupus erythematosus. Acta Paediatr Jpn 1989; 31(1):78-84. (Pubitemid 19093228)
76. Alekberova ZS, Folomeeva OM. Acute transverse myelitis in patients with systemic lupus erythematosus. Ter Arkh 1991; 63(4):110-113.
77. Moriwaka F, Tashiro K, Fukazawa T, Akino M, Yasuda I, Sagawa A, Hida K. A case of systemic lupus erythematosus -its clinical and MRI resemblance to multiple sclerosis. Jpn J Psychiatry Neurol 1990; 44(3):601-605.
78. Ito H, Nagasato K, Nakamura T, Tsujihata M, Nagataki S. Transverse myelopathy in a patient with systemic lupus erythematosus associated with positive anticardiolipin antibody -a case report. Rinsho Shinkeigaku 1992; 32(6): 639-641.
79. Mavrikakis ME, Antoniades LG, Germanides JB, Sotou D, Rassidakis A. Organic brain syndrome with psychosis as an initial manifestation of systemic lupus erythematosus in an elderly woman. Ann Rheum Dis 1992; 51(1):117-119.
80. Provenzale J, Bouldin TW. Lupus-related myelopathy: report of three cases and review of the literature. J Neurol Neurosurg Psychiatry 1992; 55(9):830-835.
81. Karmochkine M, Bironne P, Gherardi R, Jarrousse B, Glowinski J, Guillevin L. Peripheral neuropathy with epineural vasculitis and transverse myelitis in systemic lupus erythematosus. Ann Med Interne (Paris) 1993; 144(2):145-147.
82. Klaiman MD, Miller SD. Transverse myelitis complicating systemic lupus erythematosus: treatment including hydroxychloroquine. Case report. Am J Phys Med Rehabil 1993; 72(3):158-161.
83. Provenzale JM, Barboriak DP, Gaensler EH, Robertson RL, Mercer B. Lupus-related myelitis: serial MR findings. AJNR Am J Neuroradiol 1994; 15(10):1911-1917.
84. Lopez Dupla M, Khamashta MA, Sanchez AD, Ingles FP, Uriol PL, Aguado AG. Transverse myelitis as a first manifestation of systemic lupus erythematosus: a case report. Lupus 1995; 4(3):239-242.
85. Taniguchi Y, Yorioka N, Okushin S, Oda H, Usui K, Yamakido M. Usefulness of immunoadsorption therapy for systemic lupus erythematosus associated with transverse myelitis. A case report. Int J Artif Organs 1995; 18(12):799-801. (Pubitemid 26027532)
86. Espinosa-Rosales F, Berron-Perez R, Onuma-Takane E, Ortega-Martell JA. Transversal myelitis as initial manifestation of secondary antiphospholipid syndrome. Report of a case. Allergol Immunopathol (Madr) 1995; 23(5):248-250.
87. Danieli G, Gabrielli A, Montroni M, Candela M, Pomponio G, Danieli MG, Fraticelli P, Carratelli R. Neuro-SLE. Models of its clinical expresión. Recenti Prog Med 1996; 87(10):471-475.
88. Osawa H, Yamabe H, Kaizuka M, Tamura N, Tsunoda S, Shirato KI, Okumura K. Systemic lupus erythematosus associated with transverse myelitis and parkinsonian symptoms. Lupus 1997; 6(7):613-615. (Pubitemid 27406166)
89. Reiff A, Miller J, Shaham B, Bernstein B, Szer IS. Childhood central nervous system lupus; longitudinal assessment using single photon emission computed tomography. J Rheumatol 1997; 24(12):2461-11465 (Pubitemid 28005152)
90. Blanch J, Pros A, Marquez MA, Campillo MA, Marti N, Benito P. Favorable response to corticoid therapy in a patient with transverse myelitis in systemic lupus erythematosus. An Med Interna 1997; 14(12):630-632.
91. Habr F, Wu B. Acute transverse myelitis in systemic lupus erythematosus: a case of rapid diagnosis and complete recovery. Conn Med 1998; 62(7):387-390. (Pubitemid 28363582)
92. Inslicht DV, Stein AB, Pomerantz F, Ragnarsson KT. Three women with lupus transverse myelitis: case reports and differential diagnosis. Arch Phys Med Rehabil 1998; 79(4):456-459. (Pubitemid 28204628)
93. Margaux J, Hayem G, Meyer O, Kahn MF. Systemic lupus erythematosus with optical neuromyelitis (Devic's syndrome). A case with a 35-year follow-up. Rev Rhum Engl Ed 1999; 66(2):102-105.
94. al-Mayouf SM, Bahabri S. Spinal cord involvement in pediatric systemic lupus erythematosus: case report and literature review. Clin Exp Rheumatol 1999; 17(4): 505-508.
95. Romero Ganuza FJ, Sebastian de la Cruz F, La Banda Brusi F, Mazaira Alvarez J. Acute transverse myelitis in systemic lupus erythematosus. Rev Clin Esp 1999; 199(4): 218-221.
96. Bonnet F, Mercie P, Morlat P, Hocke C, Vergnes C, Ellie E, Viallard JF, Faure I, Pellegrin JL, Beylot J, Leng B. Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus. Lupus 1999; 8(3):244-247. (Pubitemid 29186845)
97. Min JK, Byun JY, Lee SH, Hong YS, Park SH, Cho CS, Kim HY. Urinary bladder involvement in patients with systemic lupus erythematosus: with review of the literature. Korean J Intern Med 2000; 15(1):42-50.
98. Neumann-Andersen G, Lindgren S. Involvement of the entire spinal cord and medulla oblongata in acute catastrophiconset transverse myelitis in SLE. Clin Rheumatol 2000; 19(2):156-160. (Pubitemid 30236150)
99. Seitz PA, Alfery DD, Robinette C. Acute transverse myelopathy after posterior cervical decompressive laminectomy and fusion. Anesth Analg 2001; 92(5):1254-1256. (Pubitemid 32385952)
100. Mouti O, Harmouch H, El Alaoui Faris M, Birouk N, Kabbaj S, Aidi S, Jiddane M, Maazouzi W, Chkili T. Acute meningomyelitis and polyradiculoneuritis disclosing systemic lupus erythematosus. Rev Neurol (Paris) 2002; 158(1):81-83.
101. Kimura KY, Seino Y, Hirayama Y, Aramaki T, Yamaguchi H, Amano H, Takano T. Systemic lupus erythematosus related transverse myelitis presenting longitudinal involvement of the spinal cord. Intern Med 2002; 41(2):156-160. (Pubitemid 34223722)
102. Yang TF, Lee SS, Lin PH, Chen H, Chan RC. Effect of selective posterior rhizotomy on transverse myelitis in a patient with systemic lupus erythematosus. Am J Phys Med Rehabil 2002; 81(6):467-468. (Pubitemid 34564120)
103. Olfat MO, Al-Mayouf SM, Muzaffer MA. Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus. Clin Rheumatol. 2004; 23(5):395-399. (Pubitemid 39386434)
104. Krishnan AV, Halmagyi GM. Acute transverse myelitis in SLE. Neurology. 2004; 62(11):2087.
105. Kato S, Ito Y, Nishino Y, Ban Y, Deguchi T. Augmentation ileocystoplasty in neurogenic bladder due to transverse myelitis in a woman with systemic lupus erythematosus. Hinyokika Kiyo 2005; 51(10): 677-680.
106. Drake WP, Byrd VM, Olsen NJ. Reactivation of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for acquired immunodeficiency syndrome. J Clin Rheumatol. 2003; 9(3): 176-180. (Pubitemid 37465876)
107. Campos LM, Kiss MH, D'Amico EA, Silva CA. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus 2003; 12(11):820-826. (Pubitemid 37463098)
108. Yamanaka F, Migita K, Ichinose K, Ohno N, Kimura H, Ishimaru H, Matsuoka Y, Eguchi K, Ezaki H. Catastrophic transverse myelitis in a patient with systemic lupus erythematosus. Mod Rheumatol 2005; 15(2):130-133 (Pubitemid 40823388)
109. Yago T, Tateishi M, Ichikawa N, Furuya T, Sakurai T, Nakajima H, Hara M, Kamatani N. A case of systemic lupus erythematosus presenting transverse myelitis after an episode of meningitis. Mod Rheumatol 2005; 15(5):367-370. (Pubitemid 41613976)
110. dos Santos VM, Correia Garcia E, Leao Rabelo F, Menezes Haase Lobo GE, Santos Damasceno MA. Transverse myelitis and chronic urticaria in systemic lupus erythematosus. Case report. Rev Med Chil 2005; 133(2):209-213.
111. Hagiwara N, Toyoda K, Uwatoko T, Yasumori K, Ibayashi S, Okada Y. Successful high dose glucocorticoid treatment for subacute neuromyelitis optica with systemic lupus erythematosus. Intern Med 2005; 44(9):998-1001. (Pubitemid 41644105)
112. Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, Jara LJ, Fraga-Mouret A, Miranda-Limon JM, Fuentes de la Mata J, Clark P, Vargas F, Alocer-Varela J. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 2005; 64(4):620-625. (Pubitemid 40469095)
113. Ferreira S, Marques P, Carneiro E, D'Cruz D, Gama G. Devic's syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome. Rheumatology (Oxford) 2005; 44(5):693-695. (Pubitemid 41487251)
114. Muraro PA, Nikolov NP, Butman JA, Abati A, Gea-Banacloche J, Gress R, Lipsky P, Illei G, Pavletic S. Granulocytic invasion of the central nervous system after hematopoietic stem cell transplantation for systemic lupus erythematosus. Haematologica. 2006; 91(6 Suppl):ECR21.
115. Jacobi C, Stingele K, Kretz R, Hartmann M, Storch-Hagenlocher B, Breitbart A, Wildemann B. Neuromyelitis optica (Devic's syndrome) as first manifestation of systemic lupus erythematosus. Lupus 2006; 15(2):107-109. (Pubitemid 43345337)
116. Bataller-Peñafiel E, Alcobendas-Maestro M, Flores-Torres I, Escalarín-De Ruz A. Mielitis transversa asociada a lupus eritematoso sistémico. Rev Neurol 2007; 45: 573-575.
117. Alexander G, Provost T, Stevens M, Alexander E. Sjögren's syndrome: central nervous system manifestations. Neurology 1981; 31:1391-1396. (Pubitemid 12228271)
118. Moll JW, Markusse HM, Pijnenburg JJ, Vecht CJ, Henzen-Logmans SC. Antineuronal antibodies in patients with neurologic complications of primary Sjogren's syndrome. Neurology 1993; 43(12):2574-2581. (Pubitemid 24004548)
119. Ohtsuka T, Saito Y, Hasegawa M, Tatsuno M, Takita S, Arita M, Okuyama K. Central nervous system disease in a child with primary Sjögren's syndrome. J Pediatr 1995; 127:961-963. (Pubitemid 126733984)
120. Harada T, Ohashi T, Miyagishi R, Fukuda H, Yoshida K, Tagawa Y, Matsuda H. Optic neuropathy and acute transverse myelopathy in primary Sjögren's syndrome. Jpn J Ophthalmol 1995; 39:162-165.
121. Kaneko Y, Suwa A, Nakajima A, Ishii A, Auki M, Tsutsumino M, Yamada T, Goto M, Uehara T, Tanaka K, Inada S. A case of primary Sjögren's syndrome accompanied by transverse myelitis. Ryumachi 1998; 38:600-604. (Pubitemid 28435885)
122. Jabbari B, Salardini A. Painful tonic/ dystonic spasms in Sjögren's syndrome. Mov Disord 1999; 14:860-864. (Pubitemid 29509634)
123. Hermisson M, Klein R, Schmidt F, Weller M, Kuker W. Myelopathy in primary Sjogren's syndrome: diagnostic and therapeutic aspects. Acta Neurol Scand. 2002; 105(6):450-453. (Pubitemid 34620572)
124. Hawley RJ, Hendricks WT. Treatment of Sjogren syndrome myelopathy with azathioprine and steroids. Arch Neurol 2002; 59(5):875.
125. Fushimi S, Nagano I, Deguchi K, Nagotani S, Murakami T, Shoji M, Abe K. A case of subacute myelitis associated with primary Sjogren syndrome showing no MRI abnormality and diagnosed by somatosensory evoked potentials. No To Shinkei. 2004; 56(12):1029-1034.
126. Nomura Y, Takatsu R, Fujisawa K, Kamo T, Sugihara H. A case of transverse myelitis caused by primary antiphospholipid antibody syndrome. Rinsho Shinkeigaku 1999; 39(9):976-978.
127. Takamura Y, Morimoto S, Tanooka A, Yoshikawa J. Transverse myelitis in a patient with primary antiphospholipid syndrome -a case report. No To Shinkei 1996; 48(9):851-855.
128. Sebastian de la Cruz F, Romero Ganuza FJ, la Banda Brusi F, Arzoz Lezaun T. Acute transverse myelitis and primary antiphospholipid syndrome. Med Clin (Barc) 1992; 99(9):342-344.
129. Arkuch Saade ME, Aladro Benito Y, Suarez Ortega S, Borges Trujillo R. Bilateral optic neuritis and transverse myelitis associated with anticardiolipin antibodies. Med Clin (Barc). 1994; 102(11):436.
130. Matsushita T, Kanda F, Yamada H, Chihara K. Recurrent acute transverse myelopathy: an 83-year-old man with antiphospholipid syndrome. Rinsho Shinkeigaku 1997; 37(11):987-991.
131. Sherer Y, Hassin S, Shoenfeld Y, Levy Y, Livneh A, Ohry A, Langevitz P. Transverse myelitis in patients with antiphospholipid antibodies -the importance of early diagnosis and treatment. Clin Rheumatol 2002; 21(3):207-210. (Pubitemid 34785008)
132. Sugie M, Yanagimoto S, Kikui S, Sugie K, Suzumura A, Takayanagi T. A case of acute transverse myelopathy and bilateral optic neuritis associated with anticardiolipin antibodies, lupus anticoagulant and perinuclear antineutrophil cytoplasmic antibodies. Rinsho Shinkeigaku 1999; 39(9): 961-966.
133. Carter D, Olchovsky D, Yonath H, Langevitz P, Ezra D. Simultaneous deep vein thrombosis and transverse myelitis with negative serology as a first sign of antiphospholipid syndrome: a case report and review of the literature. Clin Rheumatol 2006; 25(5):756-758. (Pubitemid 44111326)
134. Bhinder S, Harbour K, Majithia V. Transverse myelitis, a rare neurological manifestation of mixed connective tissue disease -a case report and a review of literature. Clin Rheumatol 2007; 26(3):445-447. (Pubitemid 46486983)
135. Mok CC, Lau CS. Transverse myelopathy complicating mixed connective tissue disease. Clin Neurol Neurosurg 1995; 97: 259-260.
136. Flechtner KM, Baum K. Mixed connective tissue disease: recurrent episodes of optic myelopathy and transverse myelopathy. Successful treatment with plasmapheresis. J Neurol Sci 1994; 126:146-148. (Pubitemid 24329770)
137. Obara K, Tanaka K. A case of mixed connective tissue disease associated with transverse myelitis responding to pulse steroid therapy. Rinsho Shinkeigaku 1991; 31:1197-1201.
138. Yamaguchi Y, Yoshimura T, Hosokawa S, Goto I. A case of mixed connective tissue disease with subacute transverse myelopathy. Rinsho Shinkeigaku 1991; 31:1099-1102.
139. Pedersen C, Bonen H, Boesen F. Transverse myelitis in mixed connective tissue disease. Clin Rheumatol 1987; 6:290-292. (Pubitemid 17138683)
140. Weiss TD, Nelson JS, Woolsey RM, Zuckner J, Baldassare AR. Transverse myelitis in mixed connective tissue disease. Arthritis Rheum 1978; 21:982-985.